Business · 30/11/1999

FDA Releases Guidance on Disclosure of Materials to Advisory Committees Convened by CDER Starting January 1, 2000

The Food and Drug Administration (FDA) has released a guidance document outlining the disclosure requirements for materials provided to advisory committees convened by the Center for Drug Evaluation and Research (CDER) starting January 1, 2000. The document clarifies FDA's interpretation of the Federal Advisory Committee Act (FACA) in this context.